| 0.673 | 0.004 | 0.673 | 5 Hydroxytryptamine antagonist | | |
| 0.619 | 0.004 | 0.619 | 5 Hydroxytryptamine 2 antagonist | | |
| 0.592 | 0.004 | 0.592 | 5 Hydroxytryptamine 2B antagonist | | |
| 0.576 | 0.003 | 0.576 | Dopamine D1 antagonist | | |
| 0.559 | 0.004 | 0.559 | Alpha 2 adrenoreceptor antagonist | | |
| 0.557 | 0.004 | 0.557 | Alpha 2b adrenoreceptor antagonist | | |
| 0.54 | 0.004 | 0.54 | 5 Hydroxytryptamine 2A antagonist | | |
| 0.503 | 0.004 | 0.503 | Alpha 2a adrenoreceptor antagonist | | |
| 0.484 | 0.005 | 0.484 | 5 Hydroxytryptamine 2C antagonist | | |
| 0.47 | 0.006 | 0.47 | Dopamine antagonist | | |
| 0.439 | 0.006 | 0.439 | Dopamine D2 antagonist | | |
| 0.438 | 0.018 | 0.438 | Anticonvulsant | | |
| 0.415 | 0.009 | 0.415 | Alpha adrenoreceptor antagonist | | |
| 0.437 | 0.056 | 0.437 | Histamine release inhibitor | | |
| 0.386 | 0.007 | 0.386 | 5 Hydroxytryptamine 1 antagonist | | |
| 0.38 | 0.005 | 0.38 | Histamine H1 receptor antagonist | | |
| 0.427 | 0.073 | 0.427 | Analgesic | | |
| 0.394 | 0.041 | 0.394 | Spasmolytic | | |
| 0.405 | 0.054 | 0.405 | Vasodilator, peripheral | | |
| 0.365 | 0.02 | 0.365 | Ca2+/calmodulin-dependent kinase II beta inhibitor | | |
| 0.372 | 0.038 | 0.372 | Hypoxia-inducible factor 1 alpha inhibitor | | |
| 0.329 | 0.005 | 0.329 | 5 Hydroxytryptamine 1F antagonist | | |
| 0.324 | 0.003 | 0.324 | Alpha 2 adrenoreceptor agonist | | |
| 0.318 | 0.008 | 0.318 | 5 Hydroxytryptamine 1A antagonist | | |
| 0.31 | 0.005 | 0.31 | Alpha adrenoreceptor agonist | | |
| 0.289 | 0.007 | 0.289 | Alpha 2c adrenoreceptor antagonist | | |
| 0.287 | 0.017 | 0.287 | Acetylcholine M1 receptor antagonist | | |
| 0.281 | 0.015 | 0.281 | Polo-like kinase-3 inhibitor | | |
| 0.251 | 0.005 | 0.251 | 5 Hydroxytryptamine 3 antagonist | | |
| 0.33 | 0.09 | 0.33 | Prostaglandin dehydrogenase inhibitor | | |
| 0.245 | 0.006 | 0.245 | 5 Hydroxytryptamine 1B antagonist | | |
| 0.277 | 0.039 | 0.277 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | | |
| 0.249 | 0.014 | 0.249 | Antihistaminic | | |
| 0.339 | 0.106 | 0.339 | 15-Lipoxygenase inhibitor | | |
| 0.239 | 0.009 | 0.239 | 5 Hydroxytryptamine 7 antagonist | | |
| 0.238 | 0.008 | 0.238 | Protein kinase C zeta inhibitor | | |
| 0.242 | 0.014 | 0.242 | Histamine antagonist | | |
| 0.266 | 0.04 | 0.266 | DNA methylase inhibitor | | |
| 0.24 | 0.016 | 0.24 | Alpha 1 adrenoreceptor antagonist | | |
| 0.231 | 0.007 | 0.231 | MAP3K9 inhibitor | | |
| 0.231 | 0.009 | 0.231 | Dopamine D3 antagonist | | |
| 0.226 | 0.004 | 0.226 | Protein kinase C iota inhibitor | | |
| 0.271 | 0.051 | 0.271 | Ca2+/calmodulin-dependent protein kinase inhibitor | | |
| 0.242 | 0.022 | 0.242 | Toll-Like receptor 9 antagonist | | |
| 0.229 | 0.012 | 0.229 | 5 Hydroxytryptamine agonist | | |
| 0.265 | 0.057 | 0.265 | Cyclic AMP phosphodiesterase inhibitor | | |
| 0.246 | 0.049 | 0.246 | DNA methyltransferase I inhibitor | | |
| 0.203 | 0.006 | 0.203 | Acetylcholine M4 receptor antagonist | | |
| 0.256 | 0.062 | 0.256 | Tyrosine 3 hydroxylase inhibitor | | |
| 0.206 | 0.023 | 0.206 | Antiadrenergic | | |
| 0.222 | 0.039 | 0.222 | Ca2+/calmodulin-dependent kinase II delta inhibitor | | |
| 0.261 | 0.079 | 0.261 | Transcription factor STAT inhibitor | | |
| 0.251 | 0.073 | 0.251 | 5 Hydroxytryptamine 1E antagonist | | |
| 0.201 | 0.023 | 0.201 | Adrenaline antagonist | | |
| 0.214 | 0.041 | 0.214 | Cytidine deaminase inhibitor | | |
| 0.212 | 0.041 | 0.212 | Antipruritic | | |
| 0.25 | 0.083 | 0.25 | Transcription factor STAT3 inhibitor | | |
| 0.191 | 0.027 | 0.191 | Acetylcholine muscarinic antagonist | | |
| 0.168 | 0.005 | 0.168 | 5 Hydroxytryptamine 6 antagonist | | |
| 0.165 | 0.005 | 0.165 | Alpha 2d adrenoreceptor antagonist | | |
| 0.175 | 0.02 | 0.175 | Alpha 1a adrenoreceptor antagonist | | |
| 0.198 | 0.043 | 0.198 | Protein kinase (CK1) gamma 1 inhibitor | | |
| 0.228 | 0.075 | 0.228 | MAP-kinase-activated kinase 5 inhibitor | | |
| 0.161 | 0.01 | 0.161 | 5 Hydroxytryptamine 1A agonist | | |
| 0.16 | 0.011 | 0.16 | Acetylcholine release stimulant | | |
| 0.216 | 0.071 | 0.216 | Platelet aggregation inhibitor | | |
| 0.146 | 0.006 | 0.146 | Dopamine D5 antagonist | | |
| 0.202 | 0.062 | 0.202 | LIM domain kinase 1 inhibitor | | |
| 0.209 | 0.07 | 0.209 | Death-associated protein kinase 3 inhibitor | | |
| 0.188 | 0.052 | 0.188 | Protein kinase C nu inhibitor | | |
| 0.157 | 0.021 | 0.157 | Alpha 1b adrenoreceptor antagonist | | |
| 0.189 | 0.054 | 0.189 | Protein kinase (CK1) gamma 3 inhibitor | | |
| 0.148 | 0.014 | 0.148 | 5 Hydroxytryptamine 1 agonist | | |
| 0.173 | 0.041 | 0.173 | Cholinergic antagonist | | |
| 0.135 | 0.005 | 0.135 | 5 Hydroxytryptamine 2 agonist | | |
| 0.146 | 0.016 | 0.146 | 5 Hydroxytryptamine uptake inhibitor | | |
| 0.132 | 0.004 | 0.132 | Glucose-6-phosphate translocase inhibitor | | |
| 0.162 | 0.034 | 0.162 | Cyclin-dependent kinase 5 inhibitor | | |
| 0.167 | 0.042 | 0.167 | Acetylcholine antagonist | | |
| 0.15 | 0.032 | 0.15 | DNA repair enzyme inhibitor | | |
| 0.134 | 0.017 | 0.134 | Alpha 1d adrenoreceptor antagonist | | |
| 0.12 | 0.004 | 0.12 | Histamine H4 receptor antagonist | | |
| 0.148 | 0.033 | 0.148 | Protein kinase C gamma inhibitor | | |
| 0.286 | 0.173 | 0.286 | DNA polymerase beta inhibitor | | |
| 0.116 | 0.004 | 0.116 | 5 Hydroxytryptamine 3B antagonist | | |
| 0.243 | 0.132 | 0.243 | Antithrombotic | | |
| 0.155 | 0.045 | 0.155 | Pregnane X receptor agonist | | |
| 0.147 | 0.037 | 0.147 | Polo-like kinase-4 inhibitor | | |
| 0.127 | 0.019 | 0.127 | Dopamine agonist | | |
| 0.131 | 0.03 | 0.131 | Anabolic | | |
| 0.133 | 0.037 | 0.133 | Mediator release inhibitor | | |
| 0.162 | 0.068 | 0.162 | Cyclin-dependent kinase 8 inhibitor | | |
| 0.127 | 0.034 | 0.127 | Nitric-oxide synthase inhibitor | | |
| 0.119 | 0.027 | 0.119 | CYP2A6 inhibitor | | |
| 0.115 | 0.024 | 0.115 | Histamine H2 receptor antagonist | | |
| 0.13 | 0.038 | 0.13 | Estrogen antagonist | | |
| 0.12 | 0.032 | 0.12 | Estrogen receptor beta antagonist | | |
| 0.192 | 0.105 | 0.192 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | | |
| 0.093 | 0.009 | 0.093 | 5 Hydroxytryptamine 2C agonist | | |
| 0.1 | 0.015 | 0.1 | 5 Hydroxytryptamine 3 agonist | | |
| 0.144 | 0.061 | 0.144 | Nav1.6 sodium channel blocker | | |
| 0.106 | 0.023 | 0.106 | Caspase 7 inhibitor | | |
| 0.181 | 0.099 | 0.181 | Histone acetyltransferase inhibitor | | |
| 0.098 | 0.017 | 0.098 | Alpha 1 adrenoreceptor agonist | | |
| 0.101 | 0.021 | 0.101 | Acetylcholine M2 receptor antagonist | | |
| 0.083 | 0.004 | 0.083 | Nerve growth factor antagonist | | |
| 0.098 | 0.019 | 0.098 | Adrenaline uptake inhibitor | | |
| 0.095 | 0.019 | 0.095 | Acetylcholine M3 receptor antagonist | | |
| 0.181 | 0.107 | 0.181 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | | |
| 0.096 | 0.024 | 0.096 | MAP3K7 inhibitor | | |
| 0.124 | 0.053 | 0.124 | 5 Hydroxytryptamine 3A agonist | | |
| 0.128 | 0.058 | 0.128 | Platelet activating factor antagonist | | |
| 0.09 | 0.02 | 0.09 | Acetylcholine M5 receptor antagonist | | |
| 0.1 | 0.031 | 0.1 | Analgesic, opioid | | |
| 0.126 | 0.058 | 0.126 | Protein kinase (CK2) alpha inhibitor | | |
| 0.095 | 0.028 | 0.095 | Dopamine D4 antagonist | | |
| 0.187 | 0.12 | 0.187 | Tumour necrosis factor alpha release inhibitor | | |
| 0.152 | 0.087 | 0.152 | Mcl-1 antagonist | | |
| 0.087 | 0.023 | 0.087 | Dopamine uptake inhibitor | | |
| 0.079 | 0.014 | 0.079 | Dopamine D2 agonist | | |
| 0.103 | 0.039 | 0.103 | Glutamate release inhibitor | | |
| 0.111 | 0.049 | 0.111 | Sphingomyelinase inhibitor | | |
| 0.075 | 0.014 | 0.075 | Farnesyltransferase inhibitor | | |
| 0.113 | 0.053 | 0.113 | Protein kinase (CK2) inhibitor | | |
| 0.114 | 0.053 | 0.114 | Nav1.1 sodium channel blocker | | |
| 0.085 | 0.024 | 0.085 | Protein kinase C beta inhibitor | | |
| 0.213 | 0.157 | 0.213 | Transcription factor NF kappa B inhibitor | | |
| 0.115 | 0.061 | 0.115 | GABA receptor agonist | | |
| 0.1 | 0.047 | 0.1 | Acetylcholine agonist | | |
| 0.089 | 0.036 | 0.089 | Estrogen receptor alpha antagonist | | |
| 0.091 | 0.038 | 0.091 | Telomerase inhibitor | | |
| 0.062 | 0.011 | 0.062 | Vasopressin 2 antagonist | | |
| 0.274 | 0.223 | 0.274 | Caspase 9 stimulant | | |
| 0.122 | 0.072 | 0.122 | Nav1.3 sodium channel blocker | | |
| 0.064 | 0.015 | 0.064 | Potassium channel small-conductance Ca-activated blocker | | |
| 0.242 | 0.196 | 0.242 | DNA directed DNA polymerase inhibitor | | |
| 0.159 | 0.116 | 0.159 | Focal adhesion kinase 2 inhibitor | | |
| 0.054 | 0.011 | 0.054 | Phenylethanolamine N methyltransferase inhibitor | | |
| 0.051 | 0.009 | 0.051 | Endothelial nitric-oxide synthase inhibitor | | |
| 0.127 | 0.085 | 0.127 | Protein kinase (CK1) inhibitor | | |
| 0.051 | 0.01 | 0.051 | 5 Hydroxytryptamine 1D agonist | | |
| 0.086 | 0.047 | 0.086 | Glutamate receptor agonist | | |
| 0.042 | 0.004 | 0.042 | NMDA receptor phencyclidine site antagonist | | |
| 0.044 | 0.006 | 0.044 | 5 Hydroxytryptamine 1F agonist | | |
| 0.051 | 0.015 | 0.051 | Acid-sensing ion channel blocker | | |
| 0.178 | 0.143 | 0.178 | 5 Hydroxytryptamine release stimulant | | |
| 0.095 | 0.06 | 0.095 | Prolactin inhibitor | | |
| 0.046 | 0.011 | 0.046 | Integrin alpha1beta1 antagonist | | |
| 0.2 | 0.165 | 0.2 | Cholesterol antagonist | | |
| 0.149 | 0.115 | 0.149 | Anesthetic general | | |
| 0.084 | 0.051 | 0.084 | Acetylcholine nicotinic agonist | | |
| 0.039 | 0.006 | 0.039 | Alpha 2d adrenoreceptor agonist | | |
| 0.047 | 0.015 | 0.047 | Opioid delta receptor agonist | | |
| 0.121 | 0.089 | 0.121 | Protein kinase (CK1) gamma inhibitor | | |
| 0.039 | 0.008 | 0.039 | 5 Hydroxytryptamine 6 agonist | | |
| 0.099 | 0.068 | 0.099 | MAP kinase kinase kinase inhibitor | | |
| 0.133 | 0.104 | 0.133 | Heat shock protein 70 antagonist | | |
| 0.064 | 0.036 | 0.064 | Glutamate (mGluR1) antagonist | | |
| 0.106 | 0.078 | 0.106 | Protein kinase (CK1) gamma 2 inhibitor | | |
| 0.058 | 0.031 | 0.058 | Opioid agonist | | |
| 0.065 | 0.038 | 0.065 | I kappa B kinase 2 inhibitor | | |
| 0.037 | 0.01 | 0.037 | Dopamine autoreceptor agonist | | |
| 0.042 | 0.015 | 0.042 | AMPA receptor agonist | | |
| 0.133 | 0.106 | 0.133 | Ca2+-transporting ATPase inhibitor | | |
| 0.147 | 0.123 | 0.147 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | | |
| 0.057 | 0.032 | 0.057 | Nicotinic receptor alpha7 subunit antagonist | | |
| 0.052 | 0.029 | 0.052 | Glutamate (mGluR group I) agonist | | |
| 0.098 | 0.076 | 0.098 | DNA intercalator | | |
| 0.063 | 0.041 | 0.063 | Prolactin release inhibitor | | |
| 0.046 | 0.025 | 0.046 | Histamine H1 receptor agonist | | |
| 0.045 | 0.025 | 0.045 | GABA B receptor antagonist | | |
| 0.041 | 0.021 | 0.041 | Kinesin antagonist | | |
| 0.041 | 0.021 | 0.041 | Kinesin-like protein 1 inhibitor | | |
| 0.061 | 0.041 | 0.061 | Enoyl-[acyl-carrier-protein] reductase inhibitor | | |
| 0.12 | 0.101 | 0.12 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | | |
| 0.041 | 0.023 | 0.041 | TRPM8 blocker | | |
| 0.063 | 0.045 | 0.063 | 5 Hydroxytryptamine 1D antagonist | | |
| 0.028 | 0.01 | 0.028 | Dopamine D1 agonist | | |
| 0.053 | 0.036 | 0.053 | 5 Hydroxytryptamine 1B agonist | | |
| 0.061 | 0.046 | 0.061 | 5 Hydroxytryptamine 2A agonist | | |
| 0.08 | 0.065 | 0.08 | Ca(v)2.2 blocker | | |
| 0.084 | 0.069 | 0.084 | Phosphodiesterase I inhibitor | | |
| 0.058 | 0.044 | 0.058 | Phosphodiesterase 1B inhibitor | | |
| 0.035 | 0.021 | 0.035 | Retinoid X alpha receptor antagonist | | |
| 0.152 | 0.138 | 0.152 | Growth factor agonist | | |
| 0.039 | 0.025 | 0.039 | Retinoid X receptor antagonist | | |
| 0.141 | 0.128 | 0.141 | Non-steroidal antiinflammatory agent | | |
| 0.052 | 0.04 | 0.052 | Nicotinic alpha7 receptor agonist | | |
| 0.024 | 0.011 | 0.024 | Imidazoline I1 receptor antagonist | | |
| 0.078 | 0.066 | 0.078 | GABA A receptor agonist | | |
| 0.04 | 0.029 | 0.04 | DNA-dependent protein kinase inhibitor | | |
| 0.052 | 0.041 | 0.052 | Acetylcholine muscarinic agonist | | |
| 0.077 | 0.068 | 0.077 | Inducible nitric-oxide synthase inhibitor | | |
| 0.037 | 0.029 | 0.037 | Alpha 1d adrenoreceptor agonist | | |
| 0.049 | 0.041 | 0.049 | 5 Hydroxytryptamine 4 antagonist | | |
| 0.118 | 0.111 | 0.118 | Cholinergic | | |
| 0.098 | 0.092 | 0.098 | Photosensitizer | | |
| 0.088 | 0.082 | 0.088 | Gastric antisecretory | | |
| 0.109 | 0.103 | 0.109 | Toll-Like receptor antagonist | | |
| 0.146 | 0.14 | 0.146 | Dyrk kinase inhibitor | | |
| 0.101 | 0.096 | 0.101 | Glutamate receptor antagonist | | |
| 0.044 | 0.04 | 0.044 | Estrogen agonist | | |
| 0.064 | 0.061 | 0.064 | Benzodiazepine agonist | | |
| 0.035 | 0.032 | 0.035 | Urate transporter 1 inhibitor | | |
| 0.019 | 0.017 | 0.019 | Adenosine kinase inhibitor | | |